A9590 Iodine i-131 iobenguane 1mci
Also known as: I-131 MIBG therapeutic, iobenguane therapy
Iodine I-131 iobenguane injection at 1 millicurie activity used therapeutically for treatment of neuroendocrine tumors.
In Plain Language
radioactive neuroendocrine tumor treatment; cancer therapy
Clinical Context
Used in targeted radiotherapy for treatment of neuroendocrine tumors, particularly pheochromocytoma and neuroblastoma.
RVU Information
CPT A9590 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
HCPCS A-codes cover medical supplies, equipment, and transport services. Documentation must establish medical necessity and include a physician order. For durable medical equipment (DME), a Certificate of Medical Necessity (CMN) or detailed written order may be required.
Specialties
Frequently Asked Questions
What is CPT code A9590?
CPT A9590 (Iodine i-131 iobenguane 1mci) is a A Codes code. Iodine I-131 iobenguane injection at 1 millicurie activity used therapeutically for treatment of neuroendocrine tumors.
Does Medicare cover A9590?
Medicare coverage for A9590 depends on medical necessity and applicable Local Coverage Determinations (LCDs). Used in targeted radiotherapy for treatment of neuroendocrine tumors, particularly pheochromocytoma and neuroblastoma. A physician order is typically required.
When is CPT A9590 used?
Used in targeted radiotherapy for treatment of neuroendocrine tumors, particularly pheochromocytoma and neuroblastoma.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against national data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.